PD-L1 protein expression by Combined Positive Score (CPS) in patients with muscle invasive or advanced urothelial carcinoma: a single institution experience

INTRODUCTION: Immune checkpoint inhibitors have revolutionized the treatment of patients with advanced urothelial carcinoma (UC) in the frontline and relapsed settings. Lebanon has one of the highest incidence of UC worldwide, yet no data exists regarding the expression of PD-L1 by Combined Positive...

Descripción completa

Detalles Bibliográficos
Autores principales: Nasr, Sarah, Haddad, Fadi G., Khazen, Joseph, Kattan, Joseph, Trak-Smayra, Viviane
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10474619/
https://www.ncbi.nlm.nih.gov/pubmed/37658290
http://dx.doi.org/10.1186/s12885-023-11299-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10474619/
https://www.ncbi.nlm.nih.gov/pubmed/37658290
http://dx.doi.org/10.1186/s12885-023-11299-y

Ejemplares similares